Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard S Schofield

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Interactive Cardiovascular and Thoracic Surgery|January 15, 2014
Close antiplatelet therapy monitoring and adjustment based upon thrombelastography may reduce late-onset bleeding in HeartMate II recipientsAshkan Karimi, Thomas M Beaver, Philip J Hess, et al.
The Annals of Thoracic Surgery|December 23, 2006
Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devicesCharles T Klodell, Timothy E Morey, Emilio B Lobato, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 24, 2005
Early outcomes of a care coordination-enhanced telehome care program for elderly veterans with chronic heart failureRichard S Schofield, Sharoen E Kline, Carsten M Schmalfuss, et al.
Journal of the American College of Cardiology|November 21, 2009
Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shockJoseph D Mishkin, Sherry J Saxonhouse, Gregory W Woo, et al.
Transplantation|March 30, 2002
Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case reportJuan M Aranda, Juan C Scornik, Sigurd J Normann, et al.
The American Journal of Cardiology|January 16, 2007
Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failureJaekyu Shin, Maximilian T Lobmeyer, Yan Gong, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 7, 2002
Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. One center's experienceJuan M Aranda, Daniel F Pauly, Richard A Kerensky, et al.
Journal of the American College of Cardiology|December 20, 2005
Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device functionJuan M Aranda, Gregory W Woo, Richard S Schofield, et al.
Clinical Cardiology|June 7, 2007
Initial heart rate and systolic blood pressure predict outcomes in chronic heart failure patients who are evaluated for cardiac transplantJuan M Aranda, Stephen E McIntyre, Charles T Klodell, et al.
Archives of Physical Medicine and Rehabilitation|April 4, 2013
Does exercise tolerance testing at 60 days poststroke predict rehabilitation performance?Dorian K Rose, Andrea L Behrman, Stephen E Nadeau, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Interactive Cardiovascular and Thoracic Surgery|January 15, 2014
Close antiplatelet therapy monitoring and adjustment based upon thrombelastography may reduce late-onset bleeding in HeartMate II recipientsAshkan Karimi, Thomas M Beaver, Philip J Hess, et al.
The Annals of Thoracic Surgery|December 23, 2006
Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devicesCharles T Klodell, Timothy E Morey, Emilio B Lobato, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 24, 2005
Early outcomes of a care coordination-enhanced telehome care program for elderly veterans with chronic heart failureRichard S Schofield, Sharoen E Kline, Carsten M Schmalfuss, et al.
Journal of the American College of Cardiology|November 21, 2009
Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shockJoseph D Mishkin, Sherry J Saxonhouse, Gregory W Woo, et al.
Transplantation|March 30, 2002
Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case reportJuan M Aranda, Juan C Scornik, Sigurd J Normann, et al.
The American Journal of Cardiology|January 16, 2007
Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failureJaekyu Shin, Maximilian T Lobmeyer, Yan Gong, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 7, 2002
Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. One center's experienceJuan M Aranda, Daniel F Pauly, Richard A Kerensky, et al.
Journal of the American College of Cardiology|December 20, 2005
Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device functionJuan M Aranda, Gregory W Woo, Richard S Schofield, et al.
Clinical Cardiology|June 7, 2007
Initial heart rate and systolic blood pressure predict outcomes in chronic heart failure patients who are evaluated for cardiac transplantJuan M Aranda, Stephen E McIntyre, Charles T Klodell, et al.
Archives of Physical Medicine and Rehabilitation|April 4, 2013
Does exercise tolerance testing at 60 days poststroke predict rehabilitation performance?Dorian K Rose, Andrea L Behrman, Stephen E Nadeau, et al.
Pageof 7